The Global Health Body Sounds Concern Over Critical Lack of Weight-Loss Injections
Under one in 10 patients that would benefit from obesity jabs including Wegovy are able to get them, warns the global health agency as it publishes its inaugural guidance on the medications.
With more than one billion people worldwide currently obese, it is advocating for more widespread and fairer availability to these injectable treatments.
Based on forecasts, more than two billion are projected to be obese by 2030 without intervention.
"The new guidelines acknowledges that obesity is a long-term condition that can be managed with comprehensive and continuous treatment," said its chief Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and distribution challenges are key hurdles to widespread access to the treatments that can assist patients in reducing considerable weight, notes the body.
Skinny Jab Scarcity
Even in the present most favorable scenario, the production of these medications could only cover approximately 100 million people – less than 10% of eligible patients, according to the health organization.
The guideline urges countries and companies to widen availability, by measures such as voluntary licensing.
The intellectual property rights on a key compound – the core ingredient of the drug Wegovy – is due to expire in a number of nations in 2026.
The Way Obesity Injections Function
GLP-1 drugs imitate a natural hormone to slow digestion, curb appetite and boost satiety so users eat less.
People commonly start to lose weight after several weeks of beginning the weekly injections.
Research indicates patients may see weight return a year later of discontinuing the medication, when their normal hunger come back.
Being above a healthy weight elevates your likelihood for contracting medical conditions, such as diabetes, heart disease, brain attack, and some cancers.
Excess weight concerns individuals in countries worldwide and was linked to millions of fatalities worldwide in 2024, as per the health agency.
